Spots Global Cancer Trial Database for Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors
Official Title: Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors
Study ID: NCT00850278
Interventions
Study Description
Brief Summary: The primary objective of this study is to assess the efficacy of the radiopharmaceutical 3'-deoxy-3'-\[F-18\]fluorothymidine, \[F-18\]FLT, a tracor of cell proliferation, using Positron Emission Tomography (PET) imaging for the tumor diagnosis and prognosis in a group of 50 patients with different type of brain tumors.\[F-18\]FLT PET imaging will be compared to the current used imaging techniques of MRI, spectroscopy imaging, PET imaging using \[11C\]MET tracer, immunohistochemical analysis and clinical parameters.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Caen University Hospital, Caen, , France
Contact Details
Name: Jean-Sébastien Guillamo, MD, PhD
Affiliation: University Hospital, Caen
Role: PRINCIPAL_INVESTIGATOR
Name: Jean-Michel Derlon, Pr
Affiliation: University Hospital, Caen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
